Other Issues

Browse Other Issues Content

Press Releases and Statements

CHPA applauds FDA’s recent emergency use authorization for a number of over-the-counter (OTC) nonprescription self-testing products for COVID-19.

Apr 2, 2021

Press Releases and Statements

CHPA released the following statement in response to new research published in Clinical Toxicology. The study found nine illegal stimulants, including deterenol, in fraudulently marketed sports and weight loss supplements.

Mar 23, 2021


The new law returns PSE to OTC status allowing consumers to purchase 3.6 grams of PSE per day, up to 7.2 grams per month.

Mar 17, 2021

Filter Results